Efficacy of sentinel node biopsy in oral cancer using 3D-CT lymphography and an indocyanine green frluorsecence guidance

Phase 2

Recruiting

• Conditions: oralcanser; oral canser

• Registration Number: JPRN-jRCTs051180087
• Lead Sponsor: Ishihara Osamu

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-03-04
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patients with previously untreated cTxN0M0 oral cancer who wasevaluated with clinical examination,ulutrasound ,CT,and or MRI,are the canditates for our stady.
Patients no having in history of previous head and neck canser,no allergy to iodne, shelfisy and ICG.

Exclusion Criteria

A history of radiation therapy to neck,or head and neck cancer pregnancy or lactating woman ,or woman with suspected pregnancy

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Identification rate of sentinellymph node by using 3D-CT lymphography and ICG fluorescence guidance.

Secondary Outcome Measures

Name	Time	Method
False negative rate of sentinel lymph node<br>2.Relations between BMI and identification rate of lymph node.